Robyn L. Schenk

752 total citations
14 papers, 495 citations indexed

About

Robyn L. Schenk is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Robyn L. Schenk has authored 14 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Robyn L. Schenk's work include Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and Immune Response and Inflammation (3 papers). Robyn L. Schenk is often cited by papers focused on Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and Immune Response and Inflammation (3 papers). Robyn L. Schenk collaborates with scholars based in Australia, Austria and Germany. Robyn L. Schenk's co-authors include Andreas Strasser, Marco J. Herold, Grant Dewson, Yifan Zhan, Emma M. Carrington, Andrew M. Lew, Lin Tai, Rebecca B. Delconte, Suzanne Cory and Nicholas D. Huntington and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Immunology.

In The Last Decade

Robyn L. Schenk

14 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robyn L. Schenk Australia	9	277	154	149	60	57	14	495
Swapna Chaudhuri India	15	229 0.8×	137 0.9×	222 1.5×	63 1.1×	30 0.5×	49	553
Cindy S. Luo Australia	9	343 1.2×	152 1.0×	151 1.0×	22 0.4×	39 0.7×	10	535
Christine Frantz Canada	8	211 0.8×	152 1.0×	98 0.7×	40 0.7×	35 0.6×	9	453
Shinji Kagaya Japan	9	227 0.8×	67 0.4×	148 1.0×	52 0.9×	20 0.4×	14	544
Komal Jhaveri United States	10	639 2.3×	140 0.9×	130 0.9×	59 1.0×	15 0.3×	17	790
Michael J. Vasconcelles United States	9	255 0.9×	178 1.2×	90 0.6×	37 0.6×	34 0.6×	20	651
Chris Tse United States	13	386 1.4×	121 0.8×	33 0.2×	36 0.6×	54 0.9×	26	630
Dan Su United States	16	517 1.9×	246 1.6×	101 0.7×	67 1.1×	16 0.3×	42	719
Suzel Davanture France	10	226 0.8×	196 1.3×	318 2.1×	32 0.5×	38 0.7×	12	643
Liu‐Mei Shou China	12	180 0.6×	135 0.9×	67 0.4×	140 2.3×	26 0.5×	20	417

Countries citing papers authored by Robyn L. Schenk

Since Specialization

Citations

This map shows the geographic impact of Robyn L. Schenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn L. Schenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn L. Schenk more than expected).

Fields of papers citing papers by Robyn L. Schenk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn L. Schenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn L. Schenk. The network helps show where Robyn L. Schenk may publish in the future.

Co-authorship network of co-authors of Robyn L. Schenk

This figure shows the co-authorship network connecting the top 25 collaborators of Robyn L. Schenk. A scholar is included among the top collaborators of Robyn L. Schenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn L. Schenk. Robyn L. Schenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hofmann, Marco H., Kaja Kostyrko, Robyn L. Schenk, et al.. (2025). SOS1 inhibition suppresses the emergence of osimertinib resistance to generate a durable response in EGFR -mutant lung cancer. Science Signaling. 18(914). eaea2788–eaea2788. 1 indexed citations

Tagoh, Hiromi, Qiong Sun, Robyn L. Schenk, et al.. (2024). Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development. Nature Immunology. 25(9). 1663–1677. 8 indexed citations

Gangoda, Lahiru, Robyn L. Schenk, Lin Tai, et al.. (2022). Removal of BFL-1 sensitises some melanoma cells to killing by BH3 mimetic drugs. Cell Death and Disease. 13(4). 301–301. 3 indexed citations

Gangoda, Lahiru, Robyn L. Schenk, Sarah A. Best, et al.. (2021). Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis. Cell Death and Differentiation. 29(1). 96–104. 7 indexed citations

Schenk, Robyn L., Lahiru Gangoda, Kate E. Lawlor, et al.. (2020). The pro-survival Bcl-2 family member A1 delays spontaneous and FAS ligand-induced apoptosis of activated neutrophils. Cell Death and Disease. 11(6). 474–474. 10 indexed citations

Mensink, Mark, Natasha S. Anstee, Mikara Robati, et al.. (2018). Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells. Cell Death and Differentiation. 25(4). 797–808. 15 indexed citations

Janic, Ana, Liz J. Valente, Matthew J. Wakefield, et al.. (2018). DNA repair processes are critical mediators of p53-dependent tumor suppression. Nature Medicine. 24(7). 947–953. 119 indexed citations

Sun, Li, Jai Rautela, Rebecca B. Delconte, et al.. (2018). GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function. Frontiers in Immunology. 9. 1922–1922. 32 indexed citations

Schenk, Robyn L., Selma Tuzlak, Emma M. Carrington, et al.. (2017). Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment. Cell Death and Differentiation. 24(3). 534–545. 51 indexed citations

10.

Tuzlak, Selma, Robyn L. Schenk, Ajithkumar Vasanthakumar, et al.. (2017). The BCL-2 pro-survival protein A1 is dispensable for T cell homeostasis on viral infection. Cell Death and Differentiation. 24(3). 523–533. 25 indexed citations

11.

Schenk, Robyn L., Andreas Strasser, & Grant Dewson. (2017). BCL-2: Long and winding path from discovery to therapeutic target. Biochemical and Biophysical Research Communications. 482(3). 459–469. 55 indexed citations

12.

Carrington, Emma M., Yifan Zhan, Jamie L. Brady, et al.. (2017). Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo. Cell Death and Differentiation. 24(5). 878–888. 116 indexed citations

13.

Summers, Robert L., Robyn L. Schenk, Wilfred D. Stein, et al.. (2014). Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite’s chloroquine resistance transporter. Proceedings of the National Academy of Sciences. 111(17). E1759–67. 52 indexed citations

14.

Schenk, Robyn L.. (1988). [Combination preparations of botanical extracts as adjuvants in oral mucosal defense].. PubMed. 39(8). 290–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact